{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:27:59Z","timestamp":1778794079732,"version":"3.51.4"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Erectile dysfunction (ED) in men is amenable to correction with Viagra in a majority of patients. The accumulated experience of prescribing Viagra across the broad continuum of men suffering from ED is sufficient for a meaningful assessment of the safety of Viagra in clinical practice. The use of Viagra necessitates caution in cardiac failure and when used within six months of acute myocardial infarction and stroke. It is inadvisable in patients with unstable angina pectoris. The co\u2010administration of Viagra with organic nitrates, for example, glyceryl trinitrate or isosorbide dinitrate, is unsafe. The relative contraindications to Viagra in cardiovascular disease are uncontrolled hypertension and impaired cardiac reserve. With respect to interactions with other drugs, the potential influence on the metabolism of Viagra by medications that affect the cytochrome\u2010P\u2010450 system does not translate into clinical effects. The vasodilatory properties of sildenafil citrate are largely responsible for unwanted effects. The most common side effects are headache, flushing (due to vasodilation), and dyspepsia (due to relaxation of the smooth muscle of the gastroesophageal sphincter with reflux). In the recommended single\u2010dose range (25\u2010100 mg), the use of Viagra for erectile dysfunction, in the absence of contraindications, is extremely safe provided the drug is taken under proper conditions.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb04082.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T18:28:53Z","timestamp":1247164133000},"page":"378-388","source":"Crossref","is-referenced-by-count":34,"title":["The Clinical Safety of Viagra"],"prefix":"10.1111","volume":"962","author":[{"given":"PETER H.C.","family":"LIM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"MOORTHY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENNETH G.F.","family":"BENTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510010089036"},{"key":"e_1_2_10_3_2","first-page":"1316","article-title":"Prevalence of impotence in the United States","volume":"19","author":"Furlow W.L.","year":"1985","journal-title":"Med. Aspects Hum. Sex"},{"key":"e_1_2_10_4_2","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psycho\u2010social correlates: results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman H.A.","year":"1994","journal-title":"J. Urol."},{"key":"e_1_2_10_5_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1152\/physrev.1995.75.1.191","article-title":"Physiology of penile erection","volume":"75","author":"Andersen K.E.","year":"1998","journal-title":"Physiol. Rev."},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-7358(96)00032-3"},{"key":"e_1_2_10_7_2","first-page":"707","article-title":"And then came Viagra","volume":"260","author":"Perrin J.","year":"1998","journal-title":"Pharmaceut. J."},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1998.00553.x"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260203"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1995.75.4.725"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00045-4"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805143382001"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00046-6"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00656-1"},{"key":"e_1_2_10_15_2","unstructured":"Centre for Drug Evaluation and Research. 1998. Food and Drug Administration. Post marketing safety of sildenafil citrate (Viagra): summary of reports of death in Viagra users received from marketing (late March through June 1998)."},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7287.651"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00044-2"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1996.10220.x"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900354"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)80103-3"},{"key":"e_1_2_10_22_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1742-1241.1998.tb08886.x","article-title":"Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a doubleblind, placebo controlled study of 329 patients","volume":"52","author":"Padma\u2010Nathan H.","year":"1998","journal-title":"Sildenafil Study Group. Int. J. Clin. Pract."},{"key":"e_1_2_10_23_2","first-page":"859","article-title":"Our clinical experience with the use of sildenafil citrate to treat erectile dysfunction","volume":"23","author":"Mayz B.O.","year":"1999","journal-title":"Acta Urol. Esp."},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00146-6"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3444"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.5.421"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67139-X"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900527"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00649-X"},{"key":"e_1_2_10_30_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000020278","article-title":"Sildenafil in the treatment of sexual dysfunction in spinal\u2010cord injured male patients","volume":"38","author":"Schmid D.M.","journal-title":"Eur. Urol."},{"key":"e_1_2_10_31_2","first-page":"76","article-title":"Sildenafil (Viagra) in the treatment of male erectile dysfunction in Nairobi","volume":"77","author":"Magoha G.A.","year":"2000","journal-title":"East Afr. Med. J."},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W"},{"key":"e_1_2_10_33_2","first-page":"115","article-title":"Effectiveness and adverse effects of sildenafil in erectile dysfunction","volume":"141","author":"Fekete F","year":"2000","journal-title":"Orv. Hetil."},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.00998.x"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00688-9"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2002.00425.x"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb04082.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb04082.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:37:43Z","timestamp":1695605863000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb04082.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb04082.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04082.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}